A new clinical Guideline is being developed for the diagnosis and management of Paget’s Disease of Bone in adults. Commisioned by the Paget's Association, the collaboration includes the European Calcified Tissue Society (ECTS) and the International Osteoporosis Foundation (IOF) who, along with the Paget’s Association, have contributed funds to the project.
The New Paget's Guideline will be officially launched to professionals attending the 8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases (also known as MolPharm), in Oxford, on Saturday 30th June 2018. You can find information about the meeting on the MolPharm website by following this link.
Publication of the Guideline
When the Guideline has been published we will provide details here.
In due course, for members of the Paget's Association, a summary of the new Guideline will be provided in our newsletter (register here to receive the 'Paget's News'). Further information will also be on this website in due course.